Stockreport

IceCure to Meet Institutional Investors at the H.C. Wainwright and Lake Street Capital Markets Conferences

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF Company presentation to focus on how IceCure's industry-leading ProSense® enables non-surgical treatment of benign and cancerous tumors and upcoming near-term regulatory [Read more]